2019 Pediatric Academic Societies Meeting: Research Updates From Our Experts

Five experts provide highlights from research they presented at the 2019 Pediatric Academic Societies (PAS) Meeting in Baltimore.

How can we safely reduce antibiotic use in babies admitted to the NICU?

In just eight months, from April to December 2018, Cleveland Clinic Fairview Hospital’s neonatal intensive care unit (NICU) reduced antibiotic use by 38%. Hany Aziz, MD, the NICU’s Medical Director, explained at PAS how they did it.

Hear his key takeaways in this brief video.

What questions do NICU parents ask during virtual visits?

Cleveland Clinic’s teleneonatology program has begun offering virtual visits for families with babies released from the NICU. As part of a pilot project, a neonatology team studied the types of questions parents asked, according to their baby’s gestation.

Anirudha Das, MD, Director of Neonatal Informatics and Telehealth at Cleveland Clinic, shared results in his presentation at PAS.

Here are some of his findings.

How to Coach Medical Trainees: Both teachers and learners must set expectations

Medical education is more than training. It’s coaching trainees to change and grow.

Sangeeta Krishna, MD, Clerkship Co-director and Fellowship Director of Pediatric Hospital Medicine at Cleveland Clinic, led an interactive workshop at the PAS meeting.

Dr. Krishna outlines the highlights of her workshop.

Why Is Retinopathy of Prematurity on the Rise?

Retinopathy of prematurity is on the rise in the U.S. — and not only in low-birthweight babies.

Hany Aly, MD, Chair of Neonatology at Cleveland Clinic, shares national statistics at PAS.

Watch this brief video for his take.

One Step Closer to Finding a Treatment for Autosomal Recessive Polycystic Kidney Disease

Autosomal recessive polycystic kidney disease is a rare genetic kidney disorder that can lead to kidney failure in children. There are no disease-specific therapies available, but Cleveland Clinic researchers are getting one step closer.

Hear Katherine Dell, MD, Vice Chair of Research at Cleveland Clinic’s Pediatric Institute, explain how novel biomarkers may be the answer.